{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T13:30:34Z","timestamp":1783517434248,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre of Poland","doi-asserted-by":"crossref","award":["2012\/05\/N\/NZ7\/03544"],"award-info":[{"award-number":["2012\/05\/N\/NZ7\/03544"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jpba.2017.03.053","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T02:48:01Z","timestamp":1491446881000},"page":"122-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Comparative pharmacodynamic analysis of imidazoline compounds using rat model of ocular mydriasis with a test of quantitative structure\u2013activity relationships"],"prefix":"10.1016","volume":"144","author":[{"given":"Joanna","family":"Raczak-Gutknecht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Nasal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Fr\u0105ckowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Kornicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franciszek","family":"S\u0105czewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Wawrzyniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Kubik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Kaliszan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2017.03.053_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7258(01)00170-X","article-title":"Imidazoline antihypertensive drugs: a critical review on their mechanism of action","volume":"93","author":"Szabo","year":"2002","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2017.03.053_bib0010","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/08037050701517133","article-title":"Do we need new antihypertensive treatments?","volume":"16","author":"Van Zwieten","year":"2007","journal-title":"Blood Press."},{"key":"10.1016\/j.jpba.2017.03.053_bib0015","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/156802607779318190","article-title":"Interest of alpha2-adrenergic agonists and antagonists in clinical practice: background, facts and perspectives","volume":"7","author":"Crassous","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jpba.2017.03.053_bib0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1467-2995.2005.00243.x","article-title":"A2-agonists in sheep: a review","volume":"33","author":"Kastner","year":"2006","journal-title":"Vet. Anaesth. Analg."},{"key":"10.1016\/j.jpba.2017.03.053_bib0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/bja\/aei063","article-title":"Perioperative myocardial infarction\u2014aetiology and prevention","volume":"95","author":"Priebe","year":"2005","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.jpba.2017.03.053_bib0030","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00000542-200202000-00016","article-title":"Efficacy of clonidine for prevention of perioperative myocardial ischemia: a critical appraisal and meta-analysis of the literature","volume":"96","author":"Nishina","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jpba.2017.03.053_bib0035","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0376-8716(98)00040-4","article-title":"Randomised double-blind comparison of lofexidine and clonidine in the out-patient treatment of opiate withdrawal","volume":"50","author":"Carnwath","year":"1998","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jpba.2017.03.053_bib0040","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1526-4610.2001.111006357.x","article-title":"An open-label dose-titration study of the efficacy and tolerability of tizanidine hydrochloride tablets in the prophylaxis of chronic daily headache","volume":"41","author":"Saper","year":"2001","journal-title":"Headache"},{"key":"10.1016\/j.jpba.2017.03.053_bib0045","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2008.10.003","article-title":"In vitro and in vivo profiling of fadolmidine, a novel potent alpha(2)-adrenoceptor agonist with local mode of action","volume":"599","author":"Lehtimaki","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jpba.2017.03.053_bib0050","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10928-016-9474-0","article-title":"The pharmacokinetics of dexmedetomidine during long-term infusion in critically ill pediatric patients. A Bayesian approach with informative priors","volume":"43","author":"Wiczling","year":"2016","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.jpba.2017.03.053_bib0055","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1021\/jm800112s","article-title":"1-[(imidazolidin-2-yl)imino]indazole. Highly \u03b12\/I 1 selective agonist: synthesis, X-ray structure, and biological activity","volume":"51","author":"S\u0105czewski","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpba.2017.03.053_bib0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jpain.2009.08.001","article-title":"Interaction of morphine with a new alpha2-adrenoceptor agonist in mice","volume":"11","author":"Sudo","year":"2010","journal-title":"J. Pain"},{"key":"10.1016\/j.jpba.2017.03.053_bib0065","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1016\/j.bmc.2016.05.043","article-title":"A combined ligand- and structure-based approach for the identification of rilmenidine-derived compounds which synergize the antitumor effects of doxorubicin","volume":"24","author":"Vucicevic","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jpba.2017.03.053_bib0070","doi-asserted-by":"crossref","first-page":"7134","DOI":"10.1016\/j.bmc.2008.06.051","article-title":"QSAR study of imidazoline antihypertensive drugs","volume":"16","author":"Nikolic","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jpba.2017.03.053_bib0075","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ejmech.2016.03.026","article-title":"Transfer of SAR information from hypotensive indazole to indole derivatives acting at alpha-adrenergic receptors: in vitro and in vivo studies","volume":"115","author":"Saczewski","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jpba.2017.03.053_bib0080","doi-asserted-by":"crossref","first-page":"298","DOI":"10.2174\/1386207311316040004","article-title":"Imidazoline-1 receptor ligands as apoptotic agents: pharmacophore modeling and virtual docking study","volume":"16","author":"Nikolic","year":"2013","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.jpba.2017.03.053_bib0085","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.2174\/138955712803832636","article-title":"Pharmacophore development and SAR studies of imidazoline receptor Ligands","volume":"12","author":"Nikolic","year":"2012","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.jpba.2017.03.053_bib0090","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejps.2014.12.014","article-title":"Prediction of blood\u2013brain barrier permeation of alpha-adrenergic and imidazoline receptor ligands using PAMPA technique and quantitative\u2013structure permeability relationship analysis","volume":"68","author":"Vucicevic","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2017.03.053_bib0095","doi-asserted-by":"crossref","first-page":"622","DOI":"10.18433\/J3JK5P","article-title":"Partial least square and hierarchical clustering in ADMET modeling: prediction of blood\u2013brain barrier permeation of alpha-adrenergic and imidazoline receptor ligands","volume":"16","author":"Nikolic","year":"2013","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jpba.2017.03.053_bib0100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jpba.2016.02.053","article-title":"Quantitative structure\u2013retention relationship of selected imidazoline derivatives on alpha1-acid glycoprotein column","volume":"127","author":"Filipic","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2017.03.053_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0160-5402(86)90002-1","article-title":"Pupillary dilation as an index of central nervous system alpha 2-adrenoceptor activation","volume":"15","author":"Koss","year":"1986","journal-title":"J. Pharmacol. Methods"},{"key":"10.1016\/j.jpba.2017.03.053_bib0110","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1734-1140(13)71006-5","article-title":"Mydriasis model in rats as a simple system to evaluate a2-Adrenergic activity of the imidazol(in)e compounds","volume":"65","author":"Raczak-Gutknecht","year":"2013","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.jpba.2017.03.053_bib0115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0378-5173(97)00267-6","article-title":"Prediction of pharmacological classification by means of chromatographic parameters processed by principal component analysis","volume":"159","author":"Nasal","year":"1997","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpba.2017.03.053_bib0120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.chroma.2015.09.003","article-title":"Simultaneous determination of hydrophobicity and dissociation constant for a large set of compounds by gradient reverse phase high performance liquid chromatography\u2013mass spectrometry technique","volume":"1416","author":"Kubik","year":"2015","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2017.03.053_bib0125","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1365-2044.1999.00659.x","article-title":"Alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role","volume":"54","author":"Khan","year":"1999","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jpba.2017.03.053_bib0130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2174\/156802607779318235","article-title":"Agonists and antagonists targeting the different alpha2-adrenoceptor subtypes","volume":"7","author":"Gentili","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jpba.2017.03.053_bib0135","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bmc.2010.11.020","article-title":"3-[(Imidazolidin-2-yl)imino]indazole ligands with selectivity for the \u03b1(2)-adrenoceptor compared to the imidazoline I(1) receptor","volume":"19","author":"S\u0105czewski","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jpba.2017.03.053_bib0140","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.pharep.2014.05.009","article-title":"Vagotomy reveals the importance of the imidazoline receptors in the cardiovascular effects of marsanidine and 7-ME-marsanidine in rats","volume":"66","author":"Boblewski","year":"2014","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.jpba.2017.03.053_bib0145","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1749-6632.1999.tb09344.x","article-title":"Novel selective compounds for the investigation of imidazoline receptors","volume":"881","author":"Hudson","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jpba.2017.03.053_bib0150","doi-asserted-by":"crossref","DOI":"10.1002\/med.20007","article-title":"Imidazoline binding sites and their ligands: an overview of the different chemical structures","author":"Dardonville","year":"2004","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jpba.2017.03.053_bib0155","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1021\/jm00222a020","article-title":"Quantitative structure\u2013activity relationships in centrally acting imidazolidines structurally related to clonidine","volume":"20","author":"Timmermans","year":"1977","journal-title":"J. Med. Chem."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517307690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517307690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T19:41:23Z","timestamp":1589744483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708517307690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":31,"alternative-id":["S0731708517307690"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2017.03.053","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative pharmacodynamic analysis of imidazoline compounds using rat model of ocular mydriasis with a test of quantitative structure\u2013activity relationships","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2017.03.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}